Brief: Catalent Q3 Revenue USD 1,070 Million Vs. IBES Estimate USD 1,120 Million
08/05/2024 21:15
May 08 (Reuters) - Catalent Q3 adjusted EBITDA USD 163 million vs. IBES estimate USD 193.7 million
Recent news on Catalent
See all newsBrief: Novo Holdings Completes Acquisition Of Catalent
Novo Nordisk rises as Catalent deal in US nears
Regulatory conditions on Novo Holdings' $16.5 bln Catalent deal fulfilled, companies say
Brief: Catalent And Novo Holdings Fulfill All Regulatory Closing Conditions For Pending Transaction
Brief: Novo Nordisk Says All Regulatory Closing Conditions Relating To Review Of Novo Holdings A/S's Pending Acquisition Of Catalent Have Been Fulfilled